MarketCap
Facebook
X
TelegramQuarterly report 2024-Q4
added 03-07-2026
EDAP TMS S.A. Total Non Current Liabilities 2011-2026 | EDAP
Annual Total Non Current Liabilities EDAP TMS S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 7.44 M | 8.22 M | 6.96 M | 5.6 M | 7.13 M | 7.88 M | 4.86 M | 6 M | 9.16 M | 3.14 M |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.16 M | 3.14 M | 6.64 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
42.5 K | $ 2.21 | -0.43 % | $ 3.45 M |  USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 12.93 | -0.92 % | $ 1.94 B | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 10.53 | 0.77 % | $ 1.42 B | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 9.69 | -13.17 % | $ 274 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.66 | -2.96 % | $ 35.9 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 8.32 | -0.48 % | $ 597 M |  Israel |
 |
Establishment Labs Holdings
ESTA
|
53.7 M | $ 65.54 | 0.81 % | $ 1.94 B |  Costa-rica |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 70.78 | -0.59 % | $ 105 B | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 37.4 | 0.16 % | $ 1.16 B | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
12.5 M | $ 13.57 | -0.62 % | $ 877 M | Israel |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.33 | - | $ 21.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | Israel |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 16.8 | -2.38 % | $ 394 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
36.4 M | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
25.7 B | $ 109.06 | -1.49 % | $ 190 B | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 9.49 | -2.57 % | $ 340 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.35 B | $ 269.13 | -0.13 % | $ 7.59 B | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 2.07 | -4.61 % | $ 1.26 M | USA |
 |
AxoGen
AXGN
|
1.61 M | $ 31.04 | -5.22 % | $ 1.43 B | USA |
 |
Align Technology
ALGN
|
184 M | $ 172.05 | -2.31 % | $ 12.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 8.93 | -1.92 % | $ 688 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 34.17 | 1.27 % | $ 5.09 K | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.74 | -0.13 % | $ 154 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
196 M | $ 0.39 | -0.46 % | $ 40.1 M | USA |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 101.34 | -1.42 % | $ 1.29 B | USA |